ABOUT US
CONTACT US
FAQ
PRIVACY POLICY
REFUND AND CANCELLATION
BLOGS
COMPANIES
REPORTS
0
U.S. (TOLL FREE)
+1 (315) 215-3225
Automative
0
U.S. (TOLL FREE)
+1 (315) 215-3225
Global Induced Pluripotent Stem Cells (iPSCs) Market Research Report 2026
Published Date: 2026-03-03
|
Report Code: QYRE-Auto-15C5854
Home | Market Reports | Business & Industrial| Pharmaceuticals & Biotech
Global Induced Pluripotent Stem Cells iPSCs Market Size Status and Forecast 2021 2027
BUY CHAPTERS

Global Induced Pluripotent Stem Cells (iPSCs) Market Research Report 2026

Code: QYRE-Auto-15C5854
Report
2026-03-03
Pages:107
QYResearch
Buy Now with 15% Discount
DESCRIPTION
TABLE OF CONTENT
TABLES & FIGURES
FEATURED COMPANIES
Fujifilm Holding Corporation (CDI)
Ncardia
Astellas Pharma Inc
Fate Therapeutics, Inc
Pluricell Biotech
Cell Inspire Biotechnology
Reprocell
Sumitomo Dainippon Pharma

Induced Pluripotent Stem Cells (iPSCs) Market Size

The global Induced Pluripotent Stem Cells (iPSCs) market was valued at US$ 142 million in 2025 and is anticipated to reach US$ 316 million by 2032, at a CAGR of 12.3% from 2026 to 2032.

Induced Pluripotent Stem Cells (iPSCs) Market

Induced Pluripotent Stem Cells (iPSCs) Market

Induced pluripotent stem cells (also known as iPS cells or iPSCs) are a type of pluripotent stem cell that can be generated directly from adult cells. The opportunities concerning a wide range of diseases including neurodegenerative, metabolic and cardiovascular diseases in a dish for cheaper and faster drug discovery. This may be particularly important in the context of monogenic rare hereditary diseases, where iPSCs can provide an alternative model system to compensate for the lack of a predictive in-vitro human model for drug discovery.
United States is the largest Induced Pluripotent Stem Cells (iPSCs) market with about 43% market share. Europe is follower, accounting for about 33% market share.
The key players are Fujifilm Holding Corporation (CDI), Ncardia, Sumitomo Dainippon Pharma, Astellas Pharma Inc, Fate Therapeutics, Inc, Pluricell Biotech, Cell Inspire Biotechnology, ReproCELL etc. Top 3 companies occupied about 73% market share.
This report delivers a comprehensive overview of the global Induced Pluripotent Stem Cells (iPSCs) market, with both quantitative and qualitative analyses, to help readers develop growth strategies, assess the competitive landscape, evaluate their position in the current market, and make informed business decisions regarding Induced Pluripotent Stem Cells (iPSCs). The Induced Pluripotent Stem Cells (iPSCs) market size, estimates, and forecasts are provided in terms of revenue (US$ millions), with 2025 as the base year and historical and forecast data for 2021–2032.
The report segments the global Induced Pluripotent Stem Cells (iPSCs) market comprehensively. Regional market sizes by Type, by Application, , and by player are also provided. For deeper insight, the report profiles the competitive landscape, key competitors, and their respective market rankings, and discusses technological trends and new product developments.
This report will assist Induced Pluripotent Stem Cells (iPSCs) manufacturers, new entrants, and companies across the industry value chain with information on revenues, sales volume, and average prices for the overall market and its sub-segments, by company, by Type, by Application, and by region.
Market Segmentation

Scope of Induced Pluripotent Stem Cells (iPSCs) Market Report

Report Metric Details
Report Name Induced Pluripotent Stem Cells (iPSCs) Market
Accounted market size in 2025 US$ 142 million
Forecasted market size in 2032 US$ 316 million
CAGR 12.3%
Base Year 2025
Forecasted years 2026 - 2032
Segment by Type
  • Human iPSCs
  • Mouse iPSCs
Segment by Application
  • Academic Research
  • Drug Development and Discovery
  • Toxicity Screening
  • Regenerative Medicine
  • Others
By Region
  • North America (United States, Canada)
  • Europe (Germany, France, UK, Italy, Russia) Rest of Europe
  • Nordic Countries
  • Asia-Pacific (China, Japan, South Korea)
  • Southeast Asia (India, Australia)
  • Rest of Asia
  • Latin America (Mexico, Brazil)
  • Rest of Latin America
  • Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of MEA)
By Company Fujifilm Holding Corporation (CDI), Ncardia, Sumitomo Dainippon Pharma, Astellas Pharma Inc, Fate Therapeutics, Inc, Pluricell Biotech, Cell Inspire Biotechnology, ReproCELL
Forecast units USD million in value
Report coverage Revenue and volume forecast, company share, competitive landscape, growth factors and trends

Chapter Outline

  • Chapter 1: Defines the scope of the report and presents an executive summary of market segments (by Type, by Application, , etc.), including the size of each segment and its future growth potential. It offers a high-level view of the current market and its likely evolution in the short, medium, and long term.
  • Chapter 2: Summarizes global and regional market size and outlines market dynamics and recent developments, including key drivers, restraints, challenges and risks for industry participants, and relevant policy analysis.
  • Chapter 3: Provides a detailed view of the competitive landscape for Induced Pluripotent Stem Cells (iPSCs) companies, covering revenue share, development plans, and mergers and acquisitions.
  • Chapter 4: Analyzes segments by Type, detailing the size and growth potential of each segment to help readers identify blue-ocean opportunities.
  • Chapter 5: Analyzes segments by Application, detailing the size and growth potential of each downstream segment to help readers identify blue-ocean opportunities.
  • Chapter 6–10: Regional deep dives (North America, Europe, Asia Pacific, Latin America, Middle East & Africa) broken down by country. Each chapter quantifies market size and growth potential by region and key countries, and outlines market development, outlook, addressable space, and capacity.
  • Chapter 11: Profiles key players, presenting essential information on leading companies, including product/ service offerings, revenue, gross margin, product introductions/portfolios, recent developments, etc.
  • Chapter 12: Key findings and conclusions of the report.

FAQ for this report

How fast is Induced Pluripotent Stem Cells (iPSCs) Market growing?

Ans: The Induced Pluripotent Stem Cells (iPSCs) Market witnessing a CAGR of 12.3% during the forecast period 2026-2032.

What is the Induced Pluripotent Stem Cells (iPSCs) Market size in 2032?

Ans: The Induced Pluripotent Stem Cells (iPSCs) Market size in 2032 will be US$ 316 million.

What is the Induced Pluripotent Stem Cells (iPSCs) Market share by region?

Ans: United States is the largest Induced Pluripotent Stem Cells (iPSCs) market with about 43% market share. Europe is follower, accounting for about 33% market share.

What is the market share of major companies in Induced Pluripotent Stem Cells (iPSCs) Market?

Ans: Top 3 companies occupied about 73% market share.

Who are the main players in the Induced Pluripotent Stem Cells (iPSCs) Market report?

Ans: The main players in the Induced Pluripotent Stem Cells (iPSCs) Market are Fujifilm Holding Corporation (CDI), Ncardia, Sumitomo Dainippon Pharma, Astellas Pharma Inc, Fate Therapeutics, Inc, Pluricell Biotech, Cell Inspire Biotechnology, ReproCELL

What are the Application segmentation covered in the Induced Pluripotent Stem Cells (iPSCs) Market report?

Ans: The Applications covered in the Induced Pluripotent Stem Cells (iPSCs) Market report are Academic Research, Drug Development and Discovery, Toxicity Screening, Regenerative Medicine, Others

What are the Type segmentation covered in the Induced Pluripotent Stem Cells (iPSCs) Market report?

Ans: The Types covered in the Induced Pluripotent Stem Cells (iPSCs) Market report are Human iPSCs, Mouse iPSCs

1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Induced Pluripotent Stem Cells (iPSCs) Market Size Growth Rate by Type: 2021 vs 2025 vs 2032
1.2.2 Human iPSCs
1.2.3 Mouse iPSCs
1.3 Market by Application
1.3.1 Global Induced Pluripotent Stem Cells (iPSCs) Market Growth by Application: 2021 vs 2025 vs 2032
1.3.2 Academic Research
1.3.3 Drug Development and Discovery
1.3.4 Toxicity Screening
1.3.5 Regenerative Medicine
1.3.6 Others
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Global Growth Trends
2.1 Global Induced Pluripotent Stem Cells (iPSCs) Market Perspective (2021–2032)
2.2 Global Induced Pluripotent Stem Cells (iPSCs) Growth Trends by Region
2.2.1 Global Induced Pluripotent Stem Cells (iPSCs) Market Size by Region: 2021 vs 2025 vs 2032
2.2.2 Induced Pluripotent Stem Cells (iPSCs) Historic Market Size by Region (2021–2026)
2.2.3 Induced Pluripotent Stem Cells (iPSCs) Forecasted Market Size by Region (2027–2032)
2.3 Induced Pluripotent Stem Cells (iPSCs) Market Dynamics
2.3.1 Induced Pluripotent Stem Cells (iPSCs) Industry Trends
2.3.2 Induced Pluripotent Stem Cells (iPSCs) Market Drivers
2.3.3 Induced Pluripotent Stem Cells (iPSCs) Market Challenges
2.3.4 Induced Pluripotent Stem Cells (iPSCs) Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Induced Pluripotent Stem Cells (iPSCs) Players by Revenue
3.1.1 Global Top Induced Pluripotent Stem Cells (iPSCs) Players by Revenue (2021–2026)
3.1.2 Global Induced Pluripotent Stem Cells (iPSCs) Revenue Market Share by Players (2021–2026)
3.2 Global Top Induced Pluripotent Stem Cells (iPSCs) Players Market Share by Company Tier (Tier 1, Tier 2, Tier 3)
3.3 Global Key Players Ranking by Induced Pluripotent Stem Cells (iPSCs) Revenue
3.4 Global Induced Pluripotent Stem Cells (iPSCs) Market Concentration Ratio
3.4.1 Global Induced Pluripotent Stem Cells (iPSCs) Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Induced Pluripotent Stem Cells (iPSCs) Revenue in 2025
3.5 Global Key Players of Induced Pluripotent Stem Cells (iPSCs) Head Offices and Areas Served
3.6 Global Key Players of Induced Pluripotent Stem Cells (iPSCs), Products and Applications
3.7 Global Key Players of Induced Pluripotent Stem Cells (iPSCs), Date of General Availability (GA)
3.8 Mergers and Acquisitions, Expansion Plans
4 Induced Pluripotent Stem Cells (iPSCs) Breakdown Data by Type
4.1 Global Induced Pluripotent Stem Cells (iPSCs) Historic Market Size by Type (2021–2026)
4.2 Global Induced Pluripotent Stem Cells (iPSCs) Forecasted Market Size by Type (2027–2032)
5 Induced Pluripotent Stem Cells (iPSCs) Breakdown Data by Application
5.1 Global Induced Pluripotent Stem Cells (iPSCs) Historic Market Size by Application (2021–2026)
5.2 Global Induced Pluripotent Stem Cells (iPSCs) Forecasted Market Size by Application (2027–2032)
6 North America
6.1 North America Induced Pluripotent Stem Cells (iPSCs) Market Size (2021–2032)
6.2 North America Induced Pluripotent Stem Cells (iPSCs) Market Growth Rate by Country: 2021 vs 2025 vs 2032
6.3 North America Induced Pluripotent Stem Cells (iPSCs) Market Size by Country (2021–2026)
6.4 North America Induced Pluripotent Stem Cells (iPSCs) Market Size by Country (2027–2032)
6.5 United States
6.6 Canada
7 Europe
7.1 Europe Induced Pluripotent Stem Cells (iPSCs) Market Size (2021–2032)
7.2 Europe Induced Pluripotent Stem Cells (iPSCs) Market Growth Rate by Country: 2021 vs 2025 vs 2032
7.3 Europe Induced Pluripotent Stem Cells (iPSCs) Market Size by Country (2021–2026)
7.4 Europe Induced Pluripotent Stem Cells (iPSCs) Market Size by Country (2027–2032)
7.5 Germany
7.6 France
7.7 U.K.
7.8 Italy
7.9 Russia
7.10 Ireland
8 Asia-Pacific
8.1 Asia-Pacific Induced Pluripotent Stem Cells (iPSCs) Market Size (2021–2032)
8.2 Asia-Pacific Induced Pluripotent Stem Cells (iPSCs) Market Growth Rate by Region: 2021 vs 2025 vs 2032
8.3 Asia-Pacific Induced Pluripotent Stem Cells (iPSCs) Market Size by Region (2021–2026)
8.4 Asia-Pacific Induced Pluripotent Stem Cells (iPSCs) Market Size by Region (2027–2032)
8.5 China
8.6 Japan
8.7 South Korea
8.8 Southeast Asia
8.9 India
8.10 Australia & New Zealand
9 Latin America
9.1 Latin America Induced Pluripotent Stem Cells (iPSCs) Market Size (2021–2032)
9.2 Latin America Induced Pluripotent Stem Cells (iPSCs) Market Growth Rate by Country: 2021 vs 2025 vs 2032
9.3 Latin America Induced Pluripotent Stem Cells (iPSCs) Market Size by Country (2021–2026)
9.4 Latin America Induced Pluripotent Stem Cells (iPSCs) Market Size by Country (2027–2032)
9.5 Mexico
9.6 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Induced Pluripotent Stem Cells (iPSCs) Market Size (2021–2032)
10.2 Middle East & Africa Induced Pluripotent Stem Cells (iPSCs) Market Growth Rate by Country: 2021 vs 2025 vs 2032
10.3 Middle East & Africa Induced Pluripotent Stem Cells (iPSCs) Market Size by Country (2021–2026)
10.4 Middle East & Africa Induced Pluripotent Stem Cells (iPSCs) Market Size by Country (2027–2032)
10.5 Israel
10.6 Saudi Arabia
10.7 UAE
11 Key Players Profiles
11.1 Fujifilm Holding Corporation (CDI)
11.1.1 Fujifilm Holding Corporation (CDI) Company Details
11.1.2 Fujifilm Holding Corporation (CDI) Business Overview
11.1.3 Fujifilm Holding Corporation (CDI) Induced Pluripotent Stem Cells (iPSCs) Introduction
11.1.4 Fujifilm Holding Corporation (CDI) Revenue in Induced Pluripotent Stem Cells (iPSCs) Business (2021–2026)
11.1.5 Fujifilm Holding Corporation (CDI) Recent Development
11.2 Ncardia
11.2.1 Ncardia Company Details
11.2.2 Ncardia Business Overview
11.2.3 Ncardia Induced Pluripotent Stem Cells (iPSCs) Introduction
11.2.4 Ncardia Revenue in Induced Pluripotent Stem Cells (iPSCs) Business (2021–2026)
11.2.5 Ncardia Recent Development
11.3 Sumitomo Dainippon Pharma
11.3.1 Sumitomo Dainippon Pharma Company Details
11.3.2 Sumitomo Dainippon Pharma Business Overview
11.3.3 Sumitomo Dainippon Pharma Induced Pluripotent Stem Cells (iPSCs) Introduction
11.3.4 Sumitomo Dainippon Pharma Revenue in Induced Pluripotent Stem Cells (iPSCs) Business (2021–2026)
11.3.5 Sumitomo Dainippon Pharma Recent Development
11.4 Astellas Pharma Inc
11.4.1 Astellas Pharma Inc Company Details
11.4.2 Astellas Pharma Inc Business Overview
11.4.3 Astellas Pharma Inc Induced Pluripotent Stem Cells (iPSCs) Introduction
11.4.4 Astellas Pharma Inc Revenue in Induced Pluripotent Stem Cells (iPSCs) Business (2021–2026)
11.4.5 Astellas Pharma Inc Recent Development
11.5 Fate Therapeutics, Inc
11.5.1 Fate Therapeutics, Inc Company Details
11.5.2 Fate Therapeutics, Inc Business Overview
11.5.3 Fate Therapeutics, Inc Induced Pluripotent Stem Cells (iPSCs) Introduction
11.5.4 Fate Therapeutics, Inc Revenue in Induced Pluripotent Stem Cells (iPSCs) Business (2021–2026)
11.5.5 Fate Therapeutics, Inc Recent Development
11.6 Pluricell Biotech
11.6.1 Pluricell Biotech Company Details
11.6.2 Pluricell Biotech Business Overview
11.6.3 Pluricell Biotech Induced Pluripotent Stem Cells (iPSCs) Introduction
11.6.4 Pluricell Biotech Revenue in Induced Pluripotent Stem Cells (iPSCs) Business (2021–2026)
11.6.5 Pluricell Biotech Recent Development
11.7 Cell Inspire Biotechnology
11.7.1 Cell Inspire Biotechnology Company Details
11.7.2 Cell Inspire Biotechnology Business Overview
11.7.3 Cell Inspire Biotechnology Induced Pluripotent Stem Cells (iPSCs) Introduction
11.7.4 Cell Inspire Biotechnology Revenue in Induced Pluripotent Stem Cells (iPSCs) Business (2021–2026)
11.7.5 Cell Inspire Biotechnology Recent Development
11.8 ReproCELL
11.8.1 ReproCELL Company Details
11.8.2 ReproCELL Business Overview
11.8.3 ReproCELL Induced Pluripotent Stem Cells (iPSCs) Introduction
11.8.4 ReproCELL Revenue in Induced Pluripotent Stem Cells (iPSCs) Business (2021–2026)
11.8.5 ReproCELL Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.1.1 Research Programs/Design
13.1.1.2 Market Size Estimation
13.1.1.3 Market Breakdown and Data Triangulation
13.1.2 Data Source
13.1.2.1 Secondary Sources
13.1.2.2 Primary Sources
13.2 Author Details
13.3 Disclaimer
FEATURED COMPANIES
Fujifilm Holding Corporation (CDI)
Ncardia
Astellas Pharma Inc
Fate Therapeutics, Inc
Pluricell Biotech
Cell Inspire Biotechnology
Reprocell
Sumitomo Dainippon Pharma
List of Tables
 Table 1. Global Induced Pluripotent Stem Cells (iPSCs) Market Size Growth Rate by Type (US$ Million): 2021 vs 2025 vs 2032
 Table 2. Key Players of Human iPSCs
 Table 3. Key Players of Mouse iPSCs
 Table 4. Global Induced Pluripotent Stem Cells (iPSCs) Market Size Growth by Application (US$ Million): 2021 vs 2025 vs 2032
 Table 5. Global Induced Pluripotent Stem Cells (iPSCs) Market Size by Region (US$ Million): 2021 vs 2025 vs 2032
 Table 6. Global Induced Pluripotent Stem Cells (iPSCs) Market Size by Region (US$ Million), 2021–2026
 Table 7. Global Induced Pluripotent Stem Cells (iPSCs) Market Share by Region (2021–2026)
 Table 8. Global Induced Pluripotent Stem Cells (iPSCs) Forecasted Market Size by Region (US$ Million), 2027–2032
 Table 9. Global Induced Pluripotent Stem Cells (iPSCs) Market Share by Region (2027–2032)
 Table 10. Induced Pluripotent Stem Cells (iPSCs) Market Trends
 Table 11. Induced Pluripotent Stem Cells (iPSCs) Market Drivers
 Table 12. Induced Pluripotent Stem Cells (iPSCs) Market Challenges
 Table 13. Induced Pluripotent Stem Cells (iPSCs) Market Restraints
 Table 14. Global Induced Pluripotent Stem Cells (iPSCs) Revenue by Players (US$ Million), 2021–2026
 Table 15. Global Induced Pluripotent Stem Cells (iPSCs) Market Share by Players (2021–2026)
 Table 16. Global Top Induced Pluripotent Stem Cells (iPSCs) Players by Tier (Tier 1, Tier 2, and Tier 3), based on Induced Pluripotent Stem Cells (iPSCs) Revenue, 2025
 Table 17. Ranking of Global Top Induced Pluripotent Stem Cells (iPSCs) Companies by Revenue (US$ Million) in 2025
 Table 18. Global 5 Largest Players Market Share by Induced Pluripotent Stem Cells (iPSCs) Revenue (CR5 and HHI), 2021–2026
 Table 19. Global Key Players of Induced Pluripotent Stem Cells (iPSCs), Headquarters and Area Served
 Table 20. Global Key Players of Induced Pluripotent Stem Cells (iPSCs), Products and Applications
 Table 21. Global Key Players of Induced Pluripotent Stem Cells (iPSCs), Date of General Availability (GA)
 Table 22. Mergers and Acquisitions, Expansion Plans
 Table 23. Global Induced Pluripotent Stem Cells (iPSCs) Market Size by Type (US$ Million), 2021–2026
 Table 24. Global Induced Pluripotent Stem Cells (iPSCs) Revenue Market Share by Type (2021–2026)
 Table 25. Global Induced Pluripotent Stem Cells (iPSCs) Forecasted Market Size by Type (US$ Million), 2027–2032
 Table 26. Global Induced Pluripotent Stem Cells (iPSCs) Revenue Market Share by Type (2027–2032)
 Table 27. Global Induced Pluripotent Stem Cells (iPSCs) Market Size by Application (US$ Million), 2021–2026
 Table 28. Global Induced Pluripotent Stem Cells (iPSCs) Revenue Market Share by Application (2021–2026)
 Table 29. Global Induced Pluripotent Stem Cells (iPSCs) Forecasted Market Size by Application (US$ Million), 2027–2032
 Table 30. Global Induced Pluripotent Stem Cells (iPSCs) Revenue Market Share by Application (2027–2032)
 Table 31. North America Induced Pluripotent Stem Cells (iPSCs) Market Size Growth Rate by Country (US$ Million): 2021 vs 2025 vs 2032
 Table 32. North America Induced Pluripotent Stem Cells (iPSCs) Market Size by Country (US$ Million), 2021–2026
 Table 33. North America Induced Pluripotent Stem Cells (iPSCs) Market Size by Country (US$ Million), 2027–2032
 Table 34. Europe Induced Pluripotent Stem Cells (iPSCs) Market Size Growth Rate by Country (US$ Million): 2021 vs 2025 vs 2032
 Table 35. Europe Induced Pluripotent Stem Cells (iPSCs) Market Size by Country (US$ Million), 2021–2026
 Table 36. Europe Induced Pluripotent Stem Cells (iPSCs) Market Size by Country (US$ Million), 2027–2032
 Table 37. Asia-Pacific Induced Pluripotent Stem Cells (iPSCs) Market Size Growth Rate by Region (US$ Million): 2021 vs 2025 vs 2032
 Table 38. Asia-Pacific Induced Pluripotent Stem Cells (iPSCs) Market Size by Region (US$ Million), 2021–2026
 Table 39. Asia-Pacific Induced Pluripotent Stem Cells (iPSCs) Market Size by Region (US$ Million), 2027–2032
 Table 40. Latin America Induced Pluripotent Stem Cells (iPSCs) Market Size Growth Rate by Country (US$ Million): 2021 vs 2025 vs 2032
 Table 41. Latin America Induced Pluripotent Stem Cells (iPSCs) Market Size by Country (US$ Million), 2021–2026
 Table 42. Latin America Induced Pluripotent Stem Cells (iPSCs) Market Size by Country (US$ Million), 2027–2032
 Table 43. Middle East & Africa Induced Pluripotent Stem Cells (iPSCs) Market Size Growth Rate by Country (US$ Million): 2021 vs 2025 vs 2032
 Table 44. Middle East & Africa Induced Pluripotent Stem Cells (iPSCs) Market Size by Country (US$ Million), 2021–2026
 Table 45. Middle East & Africa Induced Pluripotent Stem Cells (iPSCs) Market Size by Country (US$ Million), 2027–2032
 Table 46. Fujifilm Holding Corporation (CDI) Company Details
 Table 47. Fujifilm Holding Corporation (CDI) Business Overview
 Table 48. Fujifilm Holding Corporation (CDI) Induced Pluripotent Stem Cells (iPSCs) Product
 Table 49. Fujifilm Holding Corporation (CDI) Revenue in Induced Pluripotent Stem Cells (iPSCs) Business (US$ Million), 2021–2026
 Table 50. Fujifilm Holding Corporation (CDI) Recent Development
 Table 51. Ncardia Company Details
 Table 52. Ncardia Business Overview
 Table 53. Ncardia Induced Pluripotent Stem Cells (iPSCs) Product
 Table 54. Ncardia Revenue in Induced Pluripotent Stem Cells (iPSCs) Business (US$ Million), 2021–2026
 Table 55. Ncardia Recent Development
 Table 56. Sumitomo Dainippon Pharma Company Details
 Table 57. Sumitomo Dainippon Pharma Business Overview
 Table 58. Sumitomo Dainippon Pharma Induced Pluripotent Stem Cells (iPSCs) Product
 Table 59. Sumitomo Dainippon Pharma Revenue in Induced Pluripotent Stem Cells (iPSCs) Business (US$ Million), 2021–2026
 Table 60. Sumitomo Dainippon Pharma Recent Development
 Table 61. Astellas Pharma Inc Company Details
 Table 62. Astellas Pharma Inc Business Overview
 Table 63. Astellas Pharma Inc Induced Pluripotent Stem Cells (iPSCs) Product
 Table 64. Astellas Pharma Inc Revenue in Induced Pluripotent Stem Cells (iPSCs) Business (US$ Million), 2021–2026
 Table 65. Astellas Pharma Inc Recent Development
 Table 66. Fate Therapeutics, Inc Company Details
 Table 67. Fate Therapeutics, Inc Business Overview
 Table 68. Fate Therapeutics, Inc Induced Pluripotent Stem Cells (iPSCs) Product
 Table 69. Fate Therapeutics, Inc Revenue in Induced Pluripotent Stem Cells (iPSCs) Business (US$ Million), 2021–2026
 Table 70. Fate Therapeutics, Inc Recent Development
 Table 71. Pluricell Biotech Company Details
 Table 72. Pluricell Biotech Business Overview
 Table 73. Pluricell Biotech Induced Pluripotent Stem Cells (iPSCs) Product
 Table 74. Pluricell Biotech Revenue in Induced Pluripotent Stem Cells (iPSCs) Business (US$ Million), 2021–2026
 Table 75. Pluricell Biotech Recent Development
 Table 76. Cell Inspire Biotechnology Company Details
 Table 77. Cell Inspire Biotechnology Business Overview
 Table 78. Cell Inspire Biotechnology Induced Pluripotent Stem Cells (iPSCs) Product
 Table 79. Cell Inspire Biotechnology Revenue in Induced Pluripotent Stem Cells (iPSCs) Business (US$ Million), 2021–2026
 Table 80. Cell Inspire Biotechnology Recent Development
 Table 81. ReproCELL Company Details
 Table 82. ReproCELL Business Overview
 Table 83. ReproCELL Induced Pluripotent Stem Cells (iPSCs) Product
 Table 84. ReproCELL Revenue in Induced Pluripotent Stem Cells (iPSCs) Business (US$ Million), 2021–2026
 Table 85. ReproCELL Recent Development
 Table 86. Research Programs/Design for This Report
 Table 87. Key Data Information from Secondary Sources
 Table 88. Key Data Information from Primary Sources
 Table 89. Authors List of This Report


List of Figures
 Figure 1. Induced Pluripotent Stem Cells (iPSCs) Picture
 Figure 2. Global Induced Pluripotent Stem Cells (iPSCs) Market Size Comparison by Type (US$ Million), 2021–2032
 Figure 3. Global Induced Pluripotent Stem Cells (iPSCs) Market Share by Type: 2025 vs 2032
 Figure 4. Human iPSCs Features
 Figure 5. Mouse iPSCs Features
 Figure 6. Global Induced Pluripotent Stem Cells (iPSCs) Market Size by Application (US$ Million), 2021–2032
 Figure 7. Global Induced Pluripotent Stem Cells (iPSCs) Market Share by Application: 2025 vs 2032
 Figure 8. Academic Research Case Studies
 Figure 9. Drug Development and Discovery Case Studies
 Figure 10. Toxicity Screening Case Studies
 Figure 11. Regenerative Medicine Case Studies
 Figure 12. Others Case Studies
 Figure 13. Induced Pluripotent Stem Cells (iPSCs) Report Years Considered
 Figure 14. Global Induced Pluripotent Stem Cells (iPSCs) Market Size (US$ Million), Year-over-Year: 2021–2032
 Figure 15. Global Induced Pluripotent Stem Cells (iPSCs) Market Size, (US$ Million), 2021 vs 2025 vs 2032
 Figure 16. Global Induced Pluripotent Stem Cells (iPSCs) Market Share by Region: 2025 vs 2032
 Figure 17. Global Induced Pluripotent Stem Cells (iPSCs) Market Share by Players in 2025
 Figure 18. Global Induced Pluripotent Stem Cells (iPSCs) Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
 Figure 19. The Top 10 and 5 Players Market Share by Induced Pluripotent Stem Cells (iPSCs) Revenue in 2025
 Figure 20. North America Induced Pluripotent Stem Cells (iPSCs) Market Size YoY Growth (US$ Million), 2021–2032
 Figure 21. North America Induced Pluripotent Stem Cells (iPSCs) Market Share by Country (2021–2032)
 Figure 22. United States Induced Pluripotent Stem Cells (iPSCs) Market Size YoY Growth (US$ Million), 2021–2032
 Figure 23. Canada Induced Pluripotent Stem Cells (iPSCs) Market Size YoY Growth (US$ Million), 2021–2032
 Figure 24. Europe Induced Pluripotent Stem Cells (iPSCs) Market Size YoY Growth (US$ Million), 2021–2032
 Figure 25. Europe Induced Pluripotent Stem Cells (iPSCs) Market Share by Country (2021–2032)
 Figure 26. Germany Induced Pluripotent Stem Cells (iPSCs) Market Size YoY Growth (US$ Million), 2021–2032
 Figure 27. France Induced Pluripotent Stem Cells (iPSCs) Market Size YoY Growth (US$ Million), 2021–2032
 Figure 28. U.K. Induced Pluripotent Stem Cells (iPSCs) Market Size YoY Growth (US$ Million), 2021–2032
 Figure 29. Italy Induced Pluripotent Stem Cells (iPSCs) Market Size YoY Growth (US$ Million), 2021–2032
 Figure 30. Russia Induced Pluripotent Stem Cells (iPSCs) Market Size YoY Growth (US$ Million), 2021–2032
 Figure 31. Ireland Induced Pluripotent Stem Cells (iPSCs) Market Size YoY Growth (US$ Million), 2021–2032
 Figure 32. Asia-Pacific Induced Pluripotent Stem Cells (iPSCs) Market Size YoY Growth (US$ Million), 2021–2032
 Figure 33. Asia-Pacific Induced Pluripotent Stem Cells (iPSCs) Market Share by Region (2021–2032)
 Figure 34. China Induced Pluripotent Stem Cells (iPSCs) Market Size YoY Growth (US$ Million), 2021–2032
 Figure 35. Japan Induced Pluripotent Stem Cells (iPSCs) Market Size YoY Growth (US$ Million), 2021–2032
 Figure 36. South Korea Induced Pluripotent Stem Cells (iPSCs) Market Size YoY Growth (US$ Million), 2021–2032
 Figure 37. Southeast Asia Induced Pluripotent Stem Cells (iPSCs) Market Size YoY Growth (US$ Million), 2021–2032
 Figure 38. India Induced Pluripotent Stem Cells (iPSCs) Market Size YoY Growth (US$ Million), 2021–2032
 Figure 39. Australia & New Zealand Induced Pluripotent Stem Cells (iPSCs) Market Size YoY Growth (US$ Million), 2021–2032
 Figure 40. Latin America Induced Pluripotent Stem Cells (iPSCs) Market Size YoY Growth (US$ Million), 2021–2032
 Figure 41. Latin America Induced Pluripotent Stem Cells (iPSCs) Market Share by Country (2021–2032)
 Figure 42. Mexico Induced Pluripotent Stem Cells (iPSCs) Market Size YoY Growth (US$ Million), 2021–2032
 Figure 43. Brazil Induced Pluripotent Stem Cells (iPSCs) Market Size YoY Growth (US$ Million), 2021–2032
 Figure 44. Middle East & Africa Induced Pluripotent Stem Cells (iPSCs) Market Size YoY Growth (US$ Million), 2021–2032
 Figure 45. Middle East & Africa Induced Pluripotent Stem Cells (iPSCs) Market Share by Country (2021–2032)
 Figure 46. Israel Induced Pluripotent Stem Cells (iPSCs) Market Size YoY Growth (US$ Million), 2021–2032
 Figure 47. Saudi Arabia Induced Pluripotent Stem Cells (iPSCs) Market Size YoY Growth (US$ Million), 2021–2032
 Figure 48. UAE Induced Pluripotent Stem Cells (iPSCs) Market Size YoY Growth (US$ Million), 2021–2032
 Figure 49. Fujifilm Holding Corporation (CDI) Revenue Growth Rate in Induced Pluripotent Stem Cells (iPSCs) Business (2021–2026)
 Figure 50. Ncardia Revenue Growth Rate in Induced Pluripotent Stem Cells (iPSCs) Business (2021–2026)
 Figure 51. Sumitomo Dainippon Pharma Revenue Growth Rate in Induced Pluripotent Stem Cells (iPSCs) Business (2021–2026)
 Figure 52. Astellas Pharma Inc Revenue Growth Rate in Induced Pluripotent Stem Cells (iPSCs) Business (2021–2026)
 Figure 53. Fate Therapeutics, Inc Revenue Growth Rate in Induced Pluripotent Stem Cells (iPSCs) Business (2021–2026)
 Figure 54. Pluricell Biotech Revenue Growth Rate in Induced Pluripotent Stem Cells (iPSCs) Business (2021–2026)
 Figure 55. Cell Inspire Biotechnology Revenue Growth Rate in Induced Pluripotent Stem Cells (iPSCs) Business (2021–2026)
 Figure 56. ReproCELL Revenue Growth Rate in Induced Pluripotent Stem Cells (iPSCs) Business (2021–2026)
 Figure 57. Bottom-up and Top-down Approaches for This Report
 Figure 58. Data Triangulation
 Figure 59. Key Executives Interviewed
SELECT A FORMAT
Added to Cart
Electronic

$2900

Single User License
Electronic

$4350

Multi User License
Electronic

$5800

Enterprise License
Add to Cart
Buy Now (15% Discount)
INQUIRE FOR DISCOUNT

HAVE A QUERY?

INQUIRE ABOUT REPORT EMAIL US

OUR CUSTOMER

Accenture

SIMILAR REPORTS

Global Human Induced Pluripotent Stem Cells iPSCs Market Research Report 2024
Global Induced Pluripotent Stem Cells iPSCs Culture Medium Market Research Report 2024
Global iPSC Generation Kit Market Research Report 2025
Global iPSC Kit Market Research Report 2025
Global Induced Pluripotent Stem Cells Service Market Research Report 2024
Global iPSC Cell Therapies Market Research Report 2025
Global Induced Pluripotent Stem Cells Production Market Research Report 2025
Global IPS Cell Differentiation Kit Market Research Report 2025
Global Induced Pluripotent Stem Cell iPSC Reprogramming Kit Market Research Report 2025
Global iPSC Differentiation Kit Market Research Report 2025
Global iPSC Characterization Kit Market Research Report 2025
Global Human iPS Cell Characterization Kit Market Research Report 2025
Global iPSCs Expansion Medium Market Research Report 2024
Global IPS Cell derived Platelets Market Research Report 2025
Global Stem Cell Services Market Insights Forecast to 2030
Global Stem Cell Research Antibodies Market Research Report 2024
Global Human Embryonic Stem Cells HESC Market Research Report 2024
Stem Cell Drugs Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Global Synthetic Stem Cells Market Insights Forecast to 2030
Global Mouse Embryonic Stem Cell Market Research Report 2024
Call
Buy Now
REQUEST FREE SAMPLE REPORT
Support Contacts
U.S. (TOLL FREE)
+1 (425) 388-2538
THE COMPANY
OUR PRODUCTS
CUSTOMER SUPPORT
POLICES
THE COMPANY
CUSTOMER SUPPORT
OUR PRODUCTS
POLICES
Copyright © 2018 Valuates.com. All Rights Reserved.
Sitemap - Privacy Policy - Terms & Conditions